Lori Pierce: Therapies are of no use when patients can’t get off work to be treated

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As she became president of the American Society of Clinical Oncology, Lori J. Pierce decided to focus on equity in cancer care as her year-long presidential theme.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Robert A. Winn, MD
Director, VCU Massey Cancer Center; Senior associate dean for cancer innovation, VCU School of Medicine; Professor, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University
Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.
Robert A. Winn, MD
Director, VCU Massey Cancer Center; Senior associate dean for cancer innovation, VCU School of Medicine; Professor, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University

Login